Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glmind Trio 2mg/500mg/0.3mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Bioaltus Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glmind Trio 2mg/500mg/0.3mg Tablet SR

Triomind, a 2mg/500mg/0.3mg sustained-release tablet, combats type 2 diabetes in adults. This anti-diabetic combination medication regulates blood glucose. Administer Triomind with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is vital; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect; familiarize yourself with symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. Triomind is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glmind Trio 2mg/500mg/0.3mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Glmind Trio 2mg/500mg/0.3mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glmind Trio 2mg/500mg/0.3mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. Glmind Trio 2mg/500mg/0.3mg Extended-Release Tablets should be administered on an empty stomach.

Common Side effects of Glmind Trio 2mg/500mg/0.3mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glmind Trio 2mg/500mg/0.3mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glmind Trio 2mg/500mg/0.3mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer on an empty stomach.

How Glmind Trio 2mg/500mg/0.3mg Tablet SR works:

Glmind Trio extended-release tablets (2mg/500mg/0.3mg) contain a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glmind Trio 2mg/500mg/0.3mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glmind Trio 2mg/500mg/0.3mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential dangers prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glmind Trio tablet (2mg/500mg/0.3mg) is likely not safe for use while breastfeeding. Available human evidence indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Glmind Trio 2mg/500mg/0.3mg Tablet SR carries a high risk in individuals with kidney impairment and is best avoided. Patients with severe kidney disease should definitely not use this medication. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Glmind Trio 2mg/500mg/0.3mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. Individuals with mild to moderate hepatic dysfunction typically begin with a reduced Glmind Trio 2mg/500mg/0.3mg Tablet SR dosage; its administration is contraindicated in those with severe liver disease.

What if you forget to take Glmind Trio 2mg/500mg/0.3mg Tablet SR :

Should you forget to take a Glmind Trio 2mg/500mg/0.3mg Tablet SR, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glmind Trio 2mg/500mg/0.3mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glmind Trio 2mg/500mg/0.3mg Tablet SR

Glmind Trio 2mg/500mg/0.3mg SR Tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Glmind Trio 2mg/500mg/0.3mg SR Tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste, gas, stomach pain, headache, rash, and respiratory infections.
Glmind Trio 2mg/500mg/0.3mg SR Tablets are contraindicated in patients allergic to any component or excipient. Their use is also contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glmind Trio 2mg/500mg/0.3mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glmind Trio 2mg/500mg/0.3mg SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions provided. Discard any unused medication. Keep it out of reach of children, pets, and others.
Glmind Trio 2mg/500mg/0.3...
207
MRP 240
13% off